The reiteration of a Buy rating and maintenance of a $9 price target by a reputable analyst like Robert Burns from HC Wainwright & Co. could instill confidence among investors and potentially lead to a positive short-term impact on ADC Therapeutics' stock price. Analyst ratings, especially from well-regarded firms, often influence investor perception and can lead to price movements.